GO:0061913 positive regulation of growth plate cartilage chondrocyte proliferation: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061913 describes any process that increases the rate, frequency, or extent of chondrocyte multiplication in growing endochondral bone, driving expansion of the growth plate chondrocyte population.
• The term is a biological_process child of positive regulation of chondrocyte proliferation and is essential for longitudinal bone growth and endochondral ossification.
• Key positive regulators include ADGRG6, GPER1, IHH, EGFR ligands, Runx2, and 8-nitro-cGMP, which converge on chondrocyte proliferation and differentiation programs.
• Dysregulation of this process causes chondrodysplasia, reduced bone growth, and skeletal abnormalities, making it a target for skeletal disease research.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of candidate regulators in chondrocyte and growth plate systems.
• Researchers can map the regulatory network using RNA-seq, proteomics, imaging, and CRISPR library screening to identify upstream signals and downstream effectors.
Description
GO:0061913, positive regulation of growth plate cartilage chondrocyte proliferation, is a biological process that increases the multiplication of chondrocytes within the growth plate of growing endochondral bone, resulting in expansion of the chondrocyte population. This process is central to longitudinal bone growth because the growth plate relies on a tightly balanced pool of proliferating chondrocytes that subsequently undergo hypertrophy and are replaced by bone. Disruption of positive regulators leads to reduced chondrocyte proliferation and chondrodysplasia, whereas excessive or mistimed proliferation can alter skeletal proportions. Understanding GO:0061913 therefore requires identifying the signaling pathways, transcription factors, and extracellular cues that promote chondrocyte division in the growth plate. Mechanistically, positive regulation of growth plate cartilage chondrocyte proliferation is driven by G-protein-coupled receptor signaling, Indian hedgehog (IHH) signaling, epidermal growth factor (EGF) signaling, and intracellular second messengers such as 8-nitro-cGMP. These inputs converge on cell-cycle entry and progression in columnar chondrocytes, and they are integrated with differentiation programs controlled by transcription factors such as Runx2. Experimental evidence from mouse models shows that loss of ADGRG6 or GPER1 reduces chondrocyte proliferation and impairs growth plate homeostasis, while 8-nitro-cGMP administration expands growth plate cartilage. For researchers, GO:0061913 provides a precise ontology anchor for annotating genes, designing functional screens, and interpreting skeletal phenotypes. Because the term is defined by its positive regulatory effect on chondrocyte proliferation, assays must measure changes in proliferation rate, frequency, or extent within growth plate cartilage rather than merely documenting chondrocyte presence. This article synthesizes the QuickGO definition with verified literature to outline mechanisms, key genes, disease links, and CRISPR-based research strategies for GO:0061913.
positive regulation of growth plate cartilage chondrocyte proliferation At A Glance
| GO ID | GO:0061913 |
|---|---|
| GO term | positive regulation of growth plate cartilage chondrocyte proliferation |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Increases the rate, frequency, or extent of chondrocyte multiplication in growing endochondral bone, expanding the growth plate chondrocyte population |
| Parent class | positive regulation of chondrocyte proliferation |
| Related process | Endochondral ossification and longitudinal bone growth |
| Representative regulators | ADGRG6, GPER1, IHH, EGFR ligands, Runx2, 8-nitro-cGMP |
| Disease relevance | Chondrodysplasia, impaired bone growth, skeletal abnormalities |
What Is GO:0061913?
GO:0061913 is defined by QuickGO as any process that increases the rate, frequency, or extent of the multiplication or reproduction of chondrocytes in a growing endochondral bone, resulting in the expansion of a cell population. In practical terms, it covers signaling events, transcriptional programs, and microenvironmental cues that promote chondrocyte division specifically within growth plate cartilage during endochondral bone growth.
Why Is positive regulation of growth plate cartilage chondrocyte proliferation Important in Cell Biology?
GO:0061913 is important because the rate of growth plate chondrocyte proliferation directly determines longitudinal bone growth and skeletal size, and its dysregulation underlies chondrodysplasia and other skeletal disorders. Positive regulators such as ADGRG6, GPER1, and IHH maintain the proliferative pool of chondrocytes, and their loss reduces proliferation and disrupts growth plate homeostasis. Conversely, agents like 8-nitro-cGMP can expand growth plate cartilage, showing that this process is pharmacologically accessible. Because the term is defined by a positive regulatory outcome, it provides a rigorous framework for causal experiments that distinguish proliferation-promoting signals from general chondrocyte maintenance.
• Determines longitudinal bone growth by controlling the size of the proliferating chondrocyte pool.
• Loss of positive regulators such as ADGRG6 or GPER1 reduces chondrocyte proliferation and impairs growth plate homeostasis.
• 8-nitro-cGMP promotes bone growth through expansion of growth plate cartilage, demonstrating pharmacological stimulation of this process.
• Cartilage-specific overexpression of ERRγ causes chondrodysplasia and reduced chondrocyte proliferation, linking negative perturbation to disease.
• EGF signaling is a recognized pathway in endochondral ossification and chondrocyte proliferation.
• Runx2 in hypertrophic chondrocytes influences osteoclast-mediated bone resorption, connecting proliferation regulation to bone remodeling.
• Transcription factors controlling chondrocyte hypertrophy are downstream of proliferative signals and shape growth plate architecture.
• Actin-severing proteins such as adseverin regulate chondrocyte differentiation, illustrating cytoskeletal control of the proliferation-differentiation balance.
• Provides an ontology anchor for annotating skeletal phenotyping data and functional genomics screens.
• Supports development of experimental models for chondrodysplasia and growth disorders.
What Happens During positive regulation of growth plate cartilage chondrocyte proliferation?
Initiation by extracellular growth signals
In simple terms: Signals from outside the cell tell chondrocytes to start dividing.
Positive regulation of growth plate cartilage chondrocyte proliferation begins when extracellular ligands activate receptors on chondrocytes. The G protein-coupled receptor ADGRG6 maintains mouse growth plate homeostasis through IHH signaling, and its activity supports the proliferative program. G-protein-coupled estrogen receptor-1 (GPER1) positively regulates growth plate chondrocyte proliferation in female pubertal mice, showing that hormonal inputs can initiate this process. Epidermal growth factor signaling is also an established pathway in endochondral ossification, providing additional extracellular cues that promote chondrocyte proliferation.
Intracellular second messenger amplification
In simple terms: Small molecules inside the cell amplify the divide signal.
Once receptors are activated, intracellular second messengers amplify the proliferation signal. 8-Nitro-cGMP promotes bone growth through expansion of growth plate cartilage, indicating that cGMP-related signaling can positively regulate chondrocyte proliferation. These second messengers connect receptor activation to downstream effectors that drive cell-cycle entry, although the precise molecular intermediates vary by pathway.
Transcriptional control of proliferation and differentiation
In simple terms: Master transcription factors switch on genes needed for division while coordinating differentiation.
Transcriptional regulators of chondrocyte hypertrophy, including Runx2, operate downstream of proliferative signals and help coordinate the transition from proliferation to hypertrophy. Runx2 deletion in hypertrophic chondrocytes impairs osteoclast-mediated bone resorption, demonstrating that transcription factors in this program influence both proliferation and subsequent skeletal remodeling. Cartilage-specific overexpression of ERRγ results in chondrodysplasia and reduced chondrocyte proliferation, showing that transcriptional balance is critical for positive regulation of this process.
Cytoskeletal and differentiation coupling
In simple terms: The cell skeleton helps decide when to divide and when to mature.
Actin-severing proteins such as adseverin regulate chondrocyte differentiation, linking cytoskeletal dynamics to the proliferation-differentiation decision. This coupling ensures that proliferating chondrocytes remain organized in columns and eventually transition to hypertrophy in an orderly manner. Disruption of this coupling can reduce the proliferative pool and alter growth plate architecture.
Integration with IHH and growth plate homeostasis
In simple terms: A key feedback loop keeps the growth plate balanced.
Indian hedgehog (IHH) signaling is a central node through which ADGRG6 maintains growth plate homeostasis, and IHH coordinates proliferation with differentiation. Positive regulation of chondrocyte proliferation therefore depends on feedback between proliferative signals and differentiation cues, ensuring that the growth plate expands appropriately without losing organizational integrity.
Key Genes Involved in GO:0061913 positive regulation of growth plate cartilage chondrocyte proliferation
The following genes and proteins have been experimentally implicated in positive regulation of growth plate cartilage chondrocyte proliferation or closely related growth plate biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADGRG6 | G protein-coupled receptor that maintains growth plate homeostasis through IHH signaling | Mouse knockout studies show growth plate defects; key positive regulator model |
| GPER1 | G-protein-coupled estrogen receptor-1 positively regulates growth plate chondrocyte proliferation in female pubertal mice | Hormonal regulation of chondrocyte proliferation; sex-specific effects |
| IHH | Indian hedgehog signaling downstream of ADGRG6; coordinates proliferation and differentiation | Central node in growth plate homeostasis and endochondral ossification |
| EGFR | Epidermal growth factor receptor signaling pathway in endochondral ossification | Pathway-level regulation of chondrocyte proliferation |
| RUNX2 | Transcription factor controlling chondrocyte hypertrophy and osteoclast-mediated resorption | Links proliferation program to bone remodeling |
| ERRγ (ESRRG) | Nuclear receptor; cartilage-specific overexpression causes chondrodysplasia and reduced proliferation | Negative perturbation model for chondrodysplasia |
| Adseverin (SCIN) | Actin-severing protein regulating chondrocyte differentiation | Cytoskeletal control of proliferation-differentiation balance |
| 8-nitro-cGMP pathway components | Second messenger signaling that promotes bone growth via growth plate expansion | Pharmacological stimulation of chondrocyte proliferation |
| SOX9 | Master chondrogenic transcription factor (general chondrocyte biology) | Context for chondrocyte identity in growth plate studies |
| COL2A1 | Major cartilage collagen marking chondrocyte lineage | Readout of chondrocyte phenotype in proliferation assays |
| COL10A1 | Hypertrophic chondrocyte marker | Distinguishes proliferative from hypertrophic zones |
| MMP13 | Matrix metalloproteinase in hypertrophic chondrocytes | Marker of differentiation downstream of proliferation |
| VEGFA | Angiogenic factor in endochondral ossification | Couples growth plate expansion to vascular invasion |
| FGFR3 | Receptor tyrosine kinase regulating chondrocyte proliferation | Negative regulator context in growth plate signaling |
| PTHLH | Parathyroid hormone-like hormone regulating chondrocyte differentiation | Feedback with IHH in growth plate |
| WNT ligands | Secreted signals influencing chondrocyte proliferation | Upstream inputs to growth plate regulation |
| BMP ligands | Bone morphogenetic proteins regulating chondrogenesis | Context for positive regulation of proliferation |
| RUNX2 target genes | Downstream effectors of Runx2 in hypertrophic chondrocytes | Mechanistic readouts of transcription factor function |
How Is positive regulation of growth plate cartilage chondrocyte proliferation Regulated?
Positive regulation of growth plate cartilage chondrocyte proliferation is controlled by a layered network of extracellular signals, second messengers, and transcription factors. ADGRG6 maintains growth plate homeostasis through IHH signaling, placing a G protein-coupled receptor upstream of a core developmental pathway. GPER1 provides hormonal input that positively regulates chondrocyte proliferation in female pubertal mice, indicating sex- and stage-specific regulation. EGF signaling is an established pathway in endochondral ossification, and 8-nitro-cGMP can promote bone growth by expanding growth plate cartilage, showing that second messenger systems modulate this process. Transcription factors such as Runx2 and ERRγ influence the balance between proliferation and hypertrophy, with ERRγ overexpression causing chondrodysplasia and reduced proliferation. Cytoskeletal regulators like adseverin further tune the proliferation-differentiation decision. Together, these layers ensure that chondrocyte proliferation is positively regulated only when appropriate for skeletal growth.
positive regulation of growth plate cartilage chondrocyte proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADGRG6 | Growth plate homeostasis and skeletal growth defects | Cartilage-specific knockout mouse; chondrocyte cell line KO |
| GPER1 | Sex-specific regulation of chondrocyte proliferation | Pubertal female mouse knockout; hormone-treated chondrocytes |
| ERRγ (ESRRG) | Chondrodysplasia with reduced chondrocyte proliferation | Cartilage-specific overexpression mouse |
| RUNX2 | Impaired osteoclast-mediated bone resorption | Hypertrophic chondrocyte-specific deletion mouse |
| EGFR pathway | Endochondral ossification disorders | Ligand/receptor perturbation in chondrocyte cultures |
Chondrodysplasia and impaired bone growth
Disruption of positive regulators of growth plate chondrocyte proliferation causes chondrodysplasia and reduced bone growth. Cartilage-specific overexpression of ERRγ results in chondrodysplasia and reduced chondrocyte proliferation, directly linking perturbation of this process to skeletal disease. Loss of ADGRG6 impairs growth plate homeostasis through IHH signaling, further supporting the connection between positive regulation and normal skeletal development. These findings indicate that conditions with reduced chondrocyte proliferation should be evaluated for defects in GO:0061913 regulators.
Hormonal and sex-specific skeletal phenotypes
GPER1 positively regulates growth plate chondrocyte proliferation in female pubertal mice, suggesting that hormonal status and sex influence this process and may contribute to sex-specific skeletal phenotypes. This has implications for understanding growth disorders that manifest differently between males and females and for designing experiments that account for hormonal context.
Skeletal remodeling and osteoclast coupling
Runx2 deletion in hypertrophic chondrocytes impairs osteoclast-mediated bone resorption, showing that the transcriptional program downstream of chondrocyte proliferation is coupled to bone remodeling. This means that diseases affecting positive regulation of chondrocyte proliferation may also alter bone resorption and overall skeletal architecture.
Therapeutic and pharmacological relevance
8-Nitro-cGMP promotes bone growth through expansion of growth plate cartilage, demonstrating that this process can be stimulated pharmacologically. EGF signaling is also a tractable pathway in endochondral ossification, providing additional targets for therapeutic modulation. These observations support drug discovery efforts aimed at enhancing chondrocyte proliferation in growth-restricted conditions.
From positive regulation of growth plate cartilage chondrocyte proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for chondrocyte proliferation? | CRISPR knockout in chondrocyte cell line or cartilage-specific KO mouse |
| Does a specific point mutation alter positive regulation? | CRISPR point-mutation knock-in in chondrocytes |
| Does a disease variant affect growth plate proliferation? | Knock-in mouse carrying the human variant |
| Where and when is the regulator expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression enhance chondrocyte proliferation? | Cartilage-specific overexpression or lentiviral overexpression |
| Which pathways cooperate with the candidate gene? | CRISPR library screening combined with RNA-seq |
How to Study the positive regulation of growth plate cartilage chondrocyte proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis and proliferation rate | Quantifying chondrocyte proliferation in vitro and in vivo |
| Ki67 immunofluorescence | Cells in active cell cycle | Growth plate section analysis |
| RNA-seq | Transcriptome changes after perturbation | Identifying downstream pathways of ADGRG6, GPER1 |
| Histology and marker staining | Growth plate architecture and differentiation state | Assessing COL2A1, COL10A1, MMP13 patterns |
| Proteomics | Protein-level signaling changes | Mapping effectors downstream of receptors |
| Second messenger assays | Levels of cGMP-related molecules | Linking 8-nitro-cGMP to growth plate expansion |
| CRISPR library screening | Candidate regulators of proliferation | Discovery of novel positive regulators |
| In situ hybridization | Spatial expression of key genes | Localizing IHH, PTHLH, and Runx2 in growth plate |
Proliferation assays in chondrocytes
Measuring chondrocyte proliferation is the direct way to assess GO:0061913. EdU or BrdU incorporation, Ki67 staining, and cell counting in growth plate sections quantify the rate and extent of proliferation. These assays should be performed in the context of growth plate cartilage to match the ontology definition.
Transcriptomic and pathway profiling
RNA-seq of growth plate chondrocytes from knockout or overexpression models identifies transcriptional changes downstream of positive regulators such as ADGRG6 and GPER1. Pathway enrichment can reveal cooperation with IHH and EGF signaling. Comparative transcriptomics across proliferative and hypertrophic zones helps separate proliferation from differentiation effects.
Imaging and histology of the growth plate
Histological staining and immunofluorescence for markers such as COL2A1, COL10A1, and MMP13 reveal growth plate architecture and zone-specific changes. Imaging of columnar organization and growth plate length provides structural correlates of altered proliferation.
Proteomics and second messenger detection
Proteomic profiling can identify signaling effectors downstream of receptors such as ADGRG6 and GPER1. Detection of second messengers like 8-nitro-cGMP links biochemical changes to growth plate expansion. These methods complement genetic perturbation by defining the active signaling state.
How CRISPR Can Be Used to Study GO:0061913 positive regulation of growth plate cartilage chondrocyte proliferation
Knockout
CRISPR knockout of candidate genes such as ADGRG6 or GPER1 in chondrocyte cell lines or cartilage-specific mouse models tests whether the gene is required for positive regulation of growth plate chondrocyte proliferation. Reduced proliferation after knockout confirms a positive regulatory role, while unchanged proliferation suggests redundancy or context dependence.
Point Mutation
CRISPR point-mutation knock-in can model specific residues in receptors or signaling proteins to test whether particular domains are required for chondrocyte proliferation. This approach is useful for separating proliferation-promoting functions from other activities of the same protein.
Knock-in
Knock-in of reporters, tags, or human disease variants allows tracking of regulator expression and function in the growth plate. Disease-variant knock-in models can reveal how specific mutations alter positive regulation of chondrocyte proliferation and cause chondrodysplasia.
Overexpression
CRISPR-mediated or transgenic overexpression of candidate genes such as ERRγ or growth-promoting factors tests whether increased dosage enhances or disrupts chondrocyte proliferation. Overexpression of ERRγ causes chondrodysplasia and reduced proliferation, illustrating that dosage balance is critical.
How EDITGENE Supports positive regulation of growth plate cartilage chondrocyte proliferation Research
Researchers studying positive regulation of growth plate cartilage chondrocyte proliferation-related genes often need to determine whether a candidate gene is causally involved in chondrocyte division, whether a specific variant alters function, and how the gene fits into the IHH, EGF, and hormonal signaling networks. EDITGENE provides the CRISPR and screening tools required to answer these questions with publication-grade rigor.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of growth plate cartilage chondrocyte proliferation research.
Frequently Asked Questions About positive regulation of growth plate cartilage chondrocyte proliferation
What is GO:0061913?
GO:0061913 is the Gene Ontology term for positive regulation of growth plate cartilage chondrocyte proliferation, defined as any process that increases the rate, frequency, or extent of chondrocyte multiplication in growing endochondral bone, expanding the cell population.
What genes are involved in positive regulation of growth plate cartilage chondrocyte proliferation?
Key genes include ADGRG6, GPER1, IHH, EGFR pathway components, RUNX2, and ERRγ, all of which have been experimentally linked to chondrocyte proliferation or growth plate homeostasis.
Why is growth plate chondrocyte proliferation important for bone growth?
The size of the proliferating chondrocyte pool determines longitudinal bone growth, and its dysregulation causes chondrodysplasia and impaired skeletal development.
How is positive regulation of chondrocyte proliferation studied?
Researchers use proliferation assays such as EdU and Ki67 staining, RNA-seq, histology, proteomics, and CRISPR perturbation in chondrocyte and mouse models.
What happens when positive regulation of growth plate chondrocyte proliferation is lost?
Loss of regulators such as ADGRG6 or GPER1 reduces chondrocyte proliferation and impairs growth plate homeostasis, while ERRγ overexpression causes chondrodysplasia and reduced proliferation.
Can chondrocyte proliferation be stimulated pharmacologically?
Yes, 8-nitro-cGMP promotes bone growth through expansion of growth plate cartilage, demonstrating that this process can be enhanced by small molecules.
What signaling pathways regulate growth plate chondrocyte proliferation?
IHH signaling, EGF signaling, G protein-coupled receptor signaling via ADGRG6 and GPER1, and second messenger pathways such as 8-nitro-cGMP are all involved.
Which CRISPR model is best for studying GO:0061913?
The choice depends on the question: knockout tests requirement, point mutation tests specific residues, knock-in models disease variants, and overexpression tests dosage effects.
Is GO:0061913 related to chondrodysplasia?
Yes, perturbation of positive regulators such as ERRγ causes chondrodysplasia with reduced chondrocyte proliferation, linking this GO term to skeletal disease.
How does Runx2 relate to growth plate chondrocyte proliferation?
Runx2 is a transcription factor controlling chondrocyte hypertrophy, and its deletion in hypertrophic chondrocytes impairs osteoclast-mediated bone resorption, connecting the proliferation program to bone remodeling.
Conclusion
GO:0061913, positive regulation of growth plate cartilage chondrocyte proliferation, is a precisely defined biological process that captures the signals and programs promoting chondrocyte division in growing endochondral bone. Its regulators, including ADGRG6, GPER1, IHH, EGF pathway components, Runx2, and ERRγ, form a network that balances proliferation with differentiation and determines skeletal growth. Dysregulation of this process causes chondrodysplasia and impaired bone growth, making it a compelling target for skeletal disease research. CRISPR knockout, point-mutation, knock-in, overexpression, and library screening approaches provide the causal tools needed to dissect this process and identify new therapeutic opportunities. By anchoring experiments to the GO:0061913 definition, researchers can generate reproducible, publication-ready evidence about how chondrocyte proliferation is positively regulated in the growth plate.
References
- 1. Bian F et al.. 2024. The G protein-coupled receptor ADGRG6 maintains mouse growth plate homeostasis through IHH signaling.. J Bone Miner Res 39(11):1644-1658 PMID: 39236220
- 2. Solomon LA et al.. 2008. Transcriptional regulators of chondrocyte hypertrophy.. Birth Defects Res C Embryo Today 84(2):123-30 PMID: 18546336
- 3. Hoshino M et al.. 2017. 8-Nitro-cGMP promotes bone growth through expansion of growth plate cartilage.. Free Radic Biol Med 110:63-71 PMID: 28559051
- 4. Cardelli M et al.. 2013. Cartilage-specific overexpression of ERRγ results in Chondrodysplasia and reduced chondrocyte proliferation.. PLoS One 8(12):e81511 PMID: 24349082
- 5. Chou YS et al.. 2021. G-Protein-Coupled Estrogen Receptor-1 Positively Regulates the Growth Plate Chondrocyte Proliferation in Female Pubertal Mice.. Front Cell Dev Biol 9:710664 PMID: 34490260
- 6. Mangiavini L et al.. 2022. Epidermal growth factor signalling pathway in endochondral ossification: an evidence-based narrative review.. Ann Med 54(1):37-50 PMID: 34955078
- 7. Nurminsky D et al.. 2007. Regulation of chondrocyte differentiation by actin-severing protein adseverin.. Dev Biol 302(2):427-37 PMID: 17097081
- 8. Rashid H et al.. 2024. Runx2 deletion in hypertrophic chondrocytes impairs osteoclast mediated bone resorption.. Bone 181:117014 PMID: 38218304
